Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation
- 31 December 1991
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 61, 39-48
- https://doi.org/10.1016/0049-3848(91)90402-i
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitorNature, 1989
- Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanismBlood, 1989
- Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)Thrombosis Research, 1988
- The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of actionBlood, 1988
- A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractionsThrombosis Research, 1987
- A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluidJournal of Immunological Methods, 1987
- Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulationBlood, 1987
- The effects of post-heparin plasma lipases on anti-XA clotting activityThrombosis Research, 1985
- Neutralization of Heparin in Plasma by Platelet Factor 4 and Protamine SulphateBritish Journal of Haematology, 1978
- Difference in the Heparin-Neutralizing Effect of Protamine and Polybrene as Tested by ThrombotestScandinavian Journal of Clinical and Laboratory Investigation, 1963